• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Tissue type plasminogen activator, but not urokinase, exerts transformation-enhancing activity.

作者信息

De Petro G, Vartio T, Salonen E M, Vaheri A, Barlati S

出版信息

Int J Cancer. 1984 May 15;33(5):563-7. doi: 10.1002/ijc.2910330503.

DOI:10.1002/ijc.2910330503
PMID:6539304
Abstract

Previous studies have established that plasma cryoprecipitates of tumor patients, culture media of transformed cells and defined proteolytic fragments of fibronectin enhance the morphological cell transformation ( TEF activity) in cultures of chicken embryo fibroblasts infected with temperature-sensitive mutants of Rous sarcoma virus. We now report that purified human tissue type plasminogen activator (t-PA), but not urokinase (u-PA), has a similar TEF activity, at doses as low as 2 ng/ml (30 pM). Specific antibodies effectively neutralized the activity. No significant contamination (less than or equal to 1%) between the preparations of t-PA and fibronectin (FN) or its fragments ( FNdp ) was detected. The results suggest that t-PA may have a direct role in the process of morphological cell transformation in vitro.

摘要

相似文献

1
Tissue type plasminogen activator, but not urokinase, exerts transformation-enhancing activity.
Int J Cancer. 1984 May 15;33(5):563-7. doi: 10.1002/ijc.2910330503.
2
Transformation-enhancing activity of gelatin-binding fragments of fibronectin.纤连蛋白明胶结合片段的转化增强活性。
Proc Natl Acad Sci U S A. 1981 Aug;78(8):4965-9. doi: 10.1073/pnas.78.8.4965.
3
Limited cleavage of cellular fibronectin by plasminogen activator purified from transformed cells.从转化细胞中纯化的纤溶酶原激活剂对细胞纤连蛋白的有限切割。
Proc Natl Acad Sci U S A. 1987 May;84(9):2776-80. doi: 10.1073/pnas.84.9.2776.
4
Transformation-dependent activation of urokinase-type plasminogen activator by a plasmin-independent mechanism: involvement of cell surface membranes.
Proc Natl Acad Sci U S A. 1991 Sep 1;88(17):7768-72. doi: 10.1073/pnas.88.17.7768.
5
Induction of fibronectin mRNA by urokinase- and tissue-type plasminogen activator in human skin fibroblasts: differential role of u-PA and t-PA at the fibronectin protein level.
Biol Chem. 2002 Jan;383(1):177-87. doi: 10.1515/BC.2002.018.
6
Malignant transformation of human fibroblasts correlates with increased activity of receptor-bound plasminogen activator.人类成纤维细胞的恶性转化与受体结合型纤溶酶原激活物活性增加相关。
Cancer Res. 1991 Feb 15;51(4):1221-6.
7
Urokinase-type and tissue-type plasminogen activators as growth factors of human fibroblasts.尿激酶型和组织型纤溶酶原激活剂作为人成纤维细胞的生长因子。
Exp Cell Res. 1994 Jul;213(1):286-94. doi: 10.1006/excr.1994.1200.
8
Synergism of tissue-type plasminogen activator (t-PA) and single-chain urokinase-type plasminogen activator (scu-PA) on clot lysis in vitro and a mechanism for this effect.组织型纤溶酶原激活剂(t-PA)与单链尿激酶型纤溶酶原激活剂(scu-PA)在体外对血凝块溶解的协同作用及其作用机制。
Thromb Haemost. 1987 Jun 3;57(3):372-3.
9
Plasminogen activator is an apparent lymphocyte mitogen.纤溶酶原激活剂是一种明显的淋巴细胞有丝分裂原。
J Immunol. 1981 Apr;126(4):1415-20.
10
Enhanced plasminogen activator production of Syrian hamster embryo cells transformed by chemicals or the c-Ha-ras oncogene: type of plasminogen activators involved and their contribution to the transformed phenotype.化学物质或c-Ha-ras癌基因转化的叙利亚仓鼠胚胎细胞纤溶酶原激活物产生增强:所涉及的纤溶酶原激活物类型及其对转化表型的作用。
Carcinogenesis. 1989 Jul;10(7):1155-61. doi: 10.1093/carcin/10.7.1155.

引用本文的文献

1
Treatment of murine breast cancer cells with antisense RNA to the type I insulin-like growth factor receptor decreases the level of plasminogen activator transcripts, inhibits cell growth in vitro, and reduces tumorigenesis in vivo.用针对I型胰岛素样生长因子受体的反义RNA处理小鼠乳腺癌细胞,可降低纤溶酶原激活物转录本的水平,抑制体外细胞生长,并减少体内肿瘤发生。
Mol Pathol. 2002 Apr;55(2):102-9. doi: 10.1136/mp.55.2.102.
2
Oestradiol regulation of the components of the plasminogen-plasmin system in MDA-MB-231 human breast cancer cells stably expressing the oestrogen receptor.雌激素对稳定表达雌激素受体的MDA-MB-231人乳腺癌细胞中纤溶酶原-纤溶酶系统各成分的调节作用
Br J Cancer. 1998 Jul;78(1):88-95. doi: 10.1038/bjc.1998.447.
3
Urokinase-type plasminogen activator activity increases during the growth of two murine mammary adenocarcinomas with different metastasizing abilities.
在两种具有不同转移能力的小鼠乳腺腺癌生长过程中,尿激酶型纤溶酶原激活剂活性增加。
Clin Exp Metastasis. 1992 Nov;10(6):395-401. doi: 10.1007/BF00133468.